Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States (Including U.S. Territories), July 2017
暂无分享,去创建一个
M. Johansson | J. Muñoz-Jordán | S. Zaki | E. Barzilay | M. Beach | J. Harcourt | C. Ben Beard | D. Carroll | L. Petersen | D. Rose | M. Honein | H. Walke | D. Jamieson | D. Meaney-Delman | C. Gould | T. Oduyebo | S. Ellington | E. Petersen | J. Pérez-Padilla | Sarah Reagan‐Steiner | Laura J. Viens | K. Polen | E. Ades | I. Rabe | Darin S. Carroll | Maria Rivera | C. Gregory | A. Walker | Laura A. Smith | J. Nemhauser | E. Lathrop | Wendi L. Kuhnert-Tallman | S. Martin | Jessica Reichard | Michelle Noonan-Smith | Kara N. D. Polen
[1] C. Moore,et al. Serial Head and Brain Imaging of 17 Fetuses With Confirmed Zika Virus Infection in Colombia, South America. , 2017, Obstetrics and gynecology.
[2] Marie Bottomley Hartel,et al. Evaluation of Placental and Fetal Tissue Specimens for Zika Virus Infection — 50 States and District of Columbia, January–December, 2016 , 2017, MMWR. Morbidity and mortality weekly report.
[3] M. Biggerstaff,et al. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017 , 2017, MMWR. Morbidity and mortality weekly report.
[4] R. Césaire,et al. Analysis of blood from Zika virus-infected fetuses: a prospective case series. , 2017, The Lancet. Infectious diseases.
[5] Marie Bottomley Hartel,et al. Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016 , 2017, MMWR. Morbidity and mortality weekly report.
[6] Jisoo Kim,et al. Zika Virus Transmission — Region of the Americas, May 15, 2015–December 15, 2016 , 2017, MMWR. Morbidity and mortality weekly report.
[7] R. Link-Gelles,et al. Establishing a Timeline to Discontinue Routine Testing of Asymptomatic Pregnant Women for Zika Virus Infection — American Samoa, 2016–2017 , 2017, MMWR. Morbidity and mortality weekly report.
[8] R. DeBiasi,et al. Zika Virus Infection With Prolonged Maternal Viremia and Fetal Brain Abnormalities , 2017 .
[9] H. Kamel,et al. First cases of Zika virus–infected US blood donors outside states with areas of active transmission , 2017, Transfusion.
[10] R. Lanciotti,et al. Zika Virus RNA Replication and Persistence in Brain and Placental Tissue , 2017, Emerging infectious diseases.
[11] J. Muñoz-Jordán,et al. Persistence of Zika Virus in Body Fluids - Preliminary Report. , 2017, New England journal of medicine.
[12] T. Pumarola,et al. Prolonged Zika Virus Viremia during Pregnancy. , 2016, The New England journal of medicine.
[13] Jennifer L. White,et al. Zika Virus Testing Considerations: Lessons Learned from the First 80 Real-Time Reverse Transcription-PCR-Positive Cases Diagnosed in New York State , 2016, Journal of Clinical Microbiology.
[14] John T Brooks,et al. Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[15] J. Rakeman,et al. Prolonged Detection of Zika Virus RNA in Pregnant Women , 2016, Obstetrics and gynecology.
[16] S. Rasmussen,et al. Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[17] C. Beard,et al. Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[18] T. Pumarola,et al. Zika virus infection in pregnant women in Barcelona, Spain. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] A. Powers,et al. Zika Virus Disease in Colombia - Preliminary Report. , 2016, The New England journal of medicine.
[20] S. Hills,et al. Interim Guidance for Interpretation of Zika Virus Antibody Test Results. , 2016, MMWR. Morbidity and mortality weekly report.
[21] C. Blackmore,et al. Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease - Florida, 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[22] D. Musso,et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[23] P. Gething,et al. Risk factors for UK Plasmodium falciparum cases , 2014, Malaria Journal.
[24] C. Woods. False-Positive Results for Immunoglobulin M Serologic Results: Explanations and Examples. , 2013, Journal of the Pediatric Infectious Diseases Society.
[25] E. Massad,et al. Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries , 2011, Malaria Journal.
[26] R. Lanciotti,et al. Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007 , 2008, Emerging infectious diseases.
[27] A. Noga,et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. , 2005, Vector borne and zoonotic diseases.
[28] Denise A. Martin,et al. Persistence of Virus-Reactive Serum Immunoglobulin M Antibody in Confirmed West Nile Virus Encephalitis Cases , 2003, Emerging infectious diseases.
[29] N. Karabatsos,et al. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.
[30] Y. Okuno,et al. Serological studies on volunteers inoculated experimentally with a dengue virus strain in 1943. , 1983, Biken journal.
[31] S. Halstead,et al. Original antigenic sin in dengue. , 1983, The American journal of tropical medicine and hygiene.
[32] T. Monath,et al. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. , 1981, Bulletin of the World Health Organization.